Literature DB >> 24351939

Assessment of heart rate variability in breath holding children by 24 hour Holter monitoring.

Osman Yilmaz1, Murat Ciftel1, Kezban Ozturk2, Omer Kilic3, Hasan Kahveci4, Fuat Laloğlu5, Ozben Ceylan6.   

Abstract

PURPOSE: Previous studies have shown that the underlying pathophysiologic mechanism in children with breath holding may be generalised autonomic dysregulation. Thus, we performed cardiac rhythm and heart rate variability analyses using 24-hour Holter monitoring to evaluate the cardiac effects of autonomic dysregulation in children with breath-holding spells.
METHODS: We performed cardiac rhythm and heart rate analyses using 24-hour Holter monitors to evaluate the cardiac effects of autonomic dysregulation in children during a breath-holding spell. Our study group consisted of 68 children with breath-holding spells - 56 cyanotic type and 12 pallid type - and 39 healthy controls.
RESULTS: Clinical and heart rate variability results were compared between each spell type - cyanotic or pallid - and the control group; significant differences (p<0.05) in standard deviation of all NN intervals, mean of the standard deviations of all NN intervals for all 5-minute segments, percentage of differences between adjacent RR intervals >50 ms, and square root of the mean of the sum of squares of the differences between adjacent NN intervals values were found between the pallid and cyanotic groups.
CONCLUSIONS: Holter monitoring for 24 hours and heart rate variability parameters, particularly in children with pallid spells, are crucial for evaluation of cardiac rhythm changes.

Entities:  

Keywords:  sinus pauses

Mesh:

Year:  2013        PMID: 24351939     DOI: 10.1017/S1047951113002333

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  1 in total

1.  Incidental electrocardiogram abnormalities in children undergoing polysomnography.

Authors:  Ankit Amin; Maria Paola Mogavero; Raffaele Ferri; Lourdes M DelRosso
Journal:  J Clin Sleep Med       Date:  2021-12-01       Impact factor: 4.062

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.